EurekaMag.com logo
+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Recurrent colorectal carcinoma detection with repeated infusions of indium 111 zce 025 moab



Recurrent colorectal carcinoma detection with repeated infusions of indium 111 zce 025 moab



Journal of Nuclear Medicine 30(5 SUPPL): 748-749




(PDF emailed within 1 workday: $29.90)

Accession: 033119450

Download citation: RISBibTeXText



Related references

Patterns of hama development following repeated infusions of indium 111 zce 025 moab in recurrent colorectal carcinoma patients. Journal of Nuclear Medicine 30(5 SUPPL): 906, 1989

Indium 111 cyt 103 moab imaging in patients with suspected recurrent colorectal cancer rcc. Journal of Nuclear Medicine 32(5 SUPPL): 1053, 1991

Efficacy and safety of indium 111 labeled ivp zce 025 moab in colorectal carcinoma patients preliminary clinical results. Journal of Nuclear Medicine 33(5 SUPPL): 959, 1992

The effect of unlabeled fab 1 2 fragment of anti cea moab on the detection of metastatic colorectal cancer and biodistribution of indium 111 labeled fab 1 2. Journal of Nuclear Medicine 29(5 SUPPL): 834, 1988

Improved detection of hepatic lesions using MoAb B72.3 and a modified indium-111 labelling technique in patients with recurrent colon cancer. Nuclear Medicine Communications 14(8): 658-666, 1993

Detection of hepatic metastases from colorectal carcinoma using indium 111 labeled monoclonal antibody mab mskcc experience with mab indium 111. Nuclear Medicine & Biology 18(7): 705-710, 1991

Immunoscintigraphy of recurrent colorectal carcinomas with repeated injections of indium 111 zce 025 monoclonal antibody. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 379, 1990

Correlation of tumor expression of tag 72 and cea with indium 111 moab imaging of colorectal cancer. Proceedings of the American Association for Cancer Research Annual Meeting 31: 165, 1990

Indium 111 antimyosin moab uptake in recurrent ischemic disease after coronary bypass. European Journal of Nuclear Medicine 16(7): 445, 1990

Effect of unlabelled monoclonal antibody moab on biodistribution of indium 111 labelled moab. Nuclear Medicine Communications 9(8): 553-564, 1988

Role of indium-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma. Clinical Nuclear Medicine 18(8): 685-700, 1993

Lung carcinoma immunoscintigraphy with moab anti cea indium 111. European Journal of Nuclear Medicine 15(8): 538, 1989

Effect of escalating doses of nonimmunoreactive nir moab 956a on liver uptake of tumor specific indium 111 moab 956c. 1987

Indium 111-labeled antibodies in the detection of colorectal carcinoma. Acta Chirurgica Iugoslavica 50(4): 43-46, 2004

Improved indium 111 monoclonal anti cea zce 025 moab localization in colorectal cancer crc liver metastases mets by the addition of unlabeled ul zce 025. Proceedings of the American Association for Cancer Research Annual Meeting 28: 390, 1987